Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 23IQ3PO968

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Monocyte differentiation antigen CD14 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Respiratory Distress Syndrome 2 D012128 ClinicalTrials
Amyotrophic Lateral Sclerosis 2 D000690 ClinicalTrials
Dengue 2 D003715 ClinicalTrials
Respiratory Distress Syndrome 2 D012128 ClinicalTrials
Severe Acute Respiratory Syndrome 2 D045169 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109330
FDA SRS 23IQ3PO968